Technology News and Research

RSS

NKI-AVL, Elekta partner to advance cancer research

Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital have signed a strategic alliance to advance cancer research.

From Elekta 8 Jun 2012

eHealth offers Europe solutions that can help avoid healthcare crisis

Healthcare systems face enormous challenges over the coming years. The increasing demands of an aging population, the rising cost of treatments and medications, and budget shortfalls are all issues that will need to be addressed if Europeans are to continue to enjoy high standards of care. eHealth, enabled by information and communication technologies, offers Europe solutions that can help avoid healthcare crisis.

8 Jun 2012

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The drug, called FV-162, is a highly potent, orally-delivered small molecule proteasome inhibitor with significant advantages over drugs currently used to treat multiple myeloma and some forms of Non-Hodgkin's lymphoma.

8 Jun 2012

Cardinal Health to launch new technology enhancements at SNM annual meeting

At the Society of Nuclear Medicine's (SNM) 59th Annual Meeting in Miami Beach, Fla., June 9-12, Cardinal Health will introduce new technology enhancements that make it possible for hospital nuclear medicine departments and imaging centers to seamlessly improve data integration and the overall efficiency of their operations.

8 Jun 2012

BD, JDRF partner to accelerate development of glucose-sensing technology for T1D

JDRF and BD today announced an extension of their existing collaboration focused on Type 1 diabetes (T1D) to accelerate the development of BD's proprietary glucose-sensing technology which has shown promise in providing very accurate and reliable continuous glucose information.

From BD (Becton, Dickinson and Company) 8 Jun 2012

Strand, Trovagene enter MOU to license and validate HPV assay technology

Trovagene, Inc., a developer of trans-renal molecular diagnostics, and Strand Life Sciences Pvt Ltd., of Bangalore, India, have entered into a Memorandum of Understanding (MOU) to license and validate Trovagene's proprietary Human Papillomavirus (HPV) urine test and High Risk HPV DNA Assay for clinical diagnostic and carrier screening use in India and countries in the South Asian Association for Regional Cooperation.

8 Jun 2012

ReproCELL to begin commercialization of human iPS-derived neurons for Alzheimer's

ReproCELL, Inc. announces today that the company will start commercializing human iPS-derived neurons in which an Alzheimer's disease related gene has been incorporated.

8 Jun 2012

Sorrento receives $300,000 STTR grant to develop novel therapeutics against Staph infections

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) Fast Track grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, or NIH.

8 Jun 2012

Ivera Medical denies all patent infringement claims made by Catheter Connections

Ivera Medical Corporation, a company that manufactures, markets, and sells the Curos Disinfecting Port Protector, a device that disinfects and protects the entry port on needleless valves used with intravenous lines, categorically denies all claims made by Catheter Connections in their recent legal filings against Ivera.

8 Jun 2012

MicroSun receives ISO 13485:2003 certification

MicroSun Technologies, an industry leader in customized alternative power sources for the medical, commercial, military and government markets, announced today that they have achieved ISO 13485:2003 certification, a globally recognized quality standard for the medical device industry.

8 Jun 2012

Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers

Roche announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers.

From Roche Sequencing and Life Science 8 Jun 2012

Bayer introduces Certegra Workstation

Bayer Radiology & Interventional announced the introduction of the Certegra Workstation, an informatics-driven, touch‐screen hub that enables time savings and improved patient care through a powerful suite of CT Contrast Dose Management applications and a new P3T 2.0 operating environment.

8 Jun 2012

GPs to get NHS Choices rating

GP practices in England are to be given a score out of 10 on the NHS Choices website.

7 Jun 2012

Remote coaching helps improve diet and exercise habits

Study findings suggest that remote coaching supported by mobile technology and financial incentives could encourage healthier eating and physical activity habits in adults.

7 Jun 2012

CardioKinetix commences Parachute Ventricular Partitioning Device clinical trial in IHF

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has begun enrollment in PARACHUTE III, a post-market safety surveillance trial, in Germany with the CE Marked Parachute Ventricular Partitioning Device.

7 Jun 2012

CDI introduces MyCell Services

Cellular Dynamics International, Inc. (CDI), the world's largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, today announced the launch of its MyCell Services.

7 Jun 2012

Streamline Health first quarter revenues increase to $5,445,000

Streamline Health Solutions, Inc. today announced financial results for the first quarter of fiscal year 2012, ended April 30, 2012.

7 Jun 2012

$6.4 million awarded to investigate mechanisms of allergy tolerance generated by Circassia’s ToleroMune Treatment

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States’ National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia’s Toleromune® allergy therapy.

7 Jun 2012

'Every Child Deserves a 5th Birthday' weekly theme is mHealth

The Every Child Deserves a 5th Birthday theme for this week is mHealth, an e-mail alert from USAID reports.

7 Jun 2012

Risk of leukaemia and brain cancer in children could be tripled by radiation exposure from CT scans

Radiation exposure received from 2 to 3 computed tomography (CT) scans of the head in childhood (aged under 15 years)—giving a cumulative dose of around 60 mGy— can triple the risk of later developing brain cancer, while around 5 to 10 such scans (cumulative dose around 50 mGy) could triple the risk of developing leukaemia (with the differing number of scans related to different absorption rates of the brain versus the bone marrow and age at time of scanning).

7 Jun 2012

Technology News and Research

NKI-AVL, Elekta partner to advance cancer research

eHealth offers Europe solutions that can help avoid healthcare crisis

Fluorinov Pharma receives OICR grant to develop new drug against blood cancers

Cardinal Health to launch new technology enhancements at SNM annual meeting

BD, JDRF partner to accelerate development of glucose-sensing technology for T1D

Strand, Trovagene enter MOU to license and validate HPV assay technology

ReproCELL to begin commercialization of human iPS-derived neurons for Alzheimer's

Sorrento receives $300,000 STTR grant to develop novel therapeutics against Staph infections

Ivera Medical denies all patent infringement claims made by Catheter Connections

MicroSun receives ISO 13485:2003 certification

Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers

Bayer introduces Certegra Workstation

GPs to get NHS Choices rating

Remote coaching helps improve diet and exercise habits

CardioKinetix commences Parachute Ventricular Partitioning Device clinical trial in IHF

CDI introduces MyCell Services

Streamline Health first quarter revenues increase to $5,445,000

$6.4 million awarded to investigate mechanisms of allergy tolerance generated by Circassia’s ToleroMune Treatment

'Every Child Deserves a 5th Birthday' weekly theme is mHealth

Risk of leukaemia and brain cancer in children could be tripled by radiation exposure from CT scans

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News